In a world where flexible treatment options offering the possibility to take patient care outside of the clinic are increasingly prevalent, Roche’s vision in oncology is to enable patients and care teams to stay closely connected.

To achieve this, a digital patient monitoring platform was developed to enable patients on a Roche oncology medication to systematically report their symptoms to healthcare providers (HCPs). This platform supports earlier detection of adverse events and enables timely interventions, ultimately improving clinical outcomes for patients.

The brief was to launch this new solution in a way that communicates the unique value proposition of the tool to a range of different healthcare professional and patient stakeholders to ultimately facilitate trial and adoption of the tool in key global markets.